Category: low libido in women
Did you know there is an initial screening tool to assist in the assessment of Hypoactive Sexual Desire Dysfunction (HSDD)?
Low Sexual Desire is Common Sexual difficulties and concerns are common across a woman’s lifespan, increasing at midlife and beyond menopause. The DSDS (Decreased… Continue Reading →
Every Menopause Journey is Unique – Low Sexual Desire Is Common
Low Sexual Desire Is Common 1 in 3 women between the ages 40 – 64 will experience HSDD* which can severely impair relationships, mental… Continue Reading →
Video – Menopause: Will it affect my sex life? with Prof Susan Davis
Professor Susan Davis discusses how the onset of menopause may affect your sex life, as well as various treatment options.
Jean Hailes: Jean Hailes Magazine Vol. 1, 2021: Sex, anti-inflammatory foods, PMDD
From go to ‘ohh!’: Sex across the lifespan Through the course of a lifetime, a person’s sex life will ebb and flow. It can… Continue Reading →
Jean Hailes: Sex & Menopause
Sex & Menopause Menopause can affect your relationships and your sex life. Symptoms such as a dry vagina can make sex painful and you… Continue Reading →
What is HSDD?
What is HSDD? Hypoactive sexual desire dysfunction (HSDD) is an extremely common medical condition that causes distress resulting from a low sexual desire. Clinical… Continue Reading →
IMS: Sexual wellbeing after menopause
Patient Support Material: Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to… Continue Reading →
IMS: Sexual wellbeing after menopause
Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to sexuality. After menopause… Continue Reading →
AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →